12:00 AM
Jul 06, 2009
 |  BC Week In Review  |  Company News  |  Other News

Oncoscience, YM BioSciences, CIMAB cancer news

YM's CIM YM BioSciences Inc. subsidiary, which is partly owned by CIMAB, said it will continue its deal with Oncoscience and will not file for arbitration. In November, YM said it would seek arbitration alleging that Oncoscience's...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >